5/6/2010 Sarah O'Brien, MD, MSc Curriculum Vitae Current Position ...

1,685 views

Published on

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
1,685
On SlideShare
0
From Embeds
0
Number of Embeds
3
Actions
Shares
0
Downloads
5
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

5/6/2010 Sarah O'Brien, MD, MSc Curriculum Vitae Current Position ...

  1. 1. 5/6/2010 Sarah O'Brien, MD, MSc Curriculum Vitae Current Position: Assistant Professor of Pediatrics, Division of Hematology/Oncology, The Ohio State University Investigator, Center for Innovation in Pediatric Practice, The Research Institute at Nationwide Children’s Hospital Work Address: 700 Children’s Drive Suite JW4986 Columbus, OH 43205 Work Phone: 614/722-3066 Email: sarah.obrien@nationwidechildrens.org Education/Training: 1992-96 University of Virginia, BA, Interdisciplinary Studies/Echols Scholar 1996-00 University of Pittsburgh, MD, Medicine 2000-03 Children’s Hospital of Pittsburgh, Pediatrics Residency 2003-06 Children’s Hospital of Pittsburgh, Pediatric Hematology/Oncology Fellowship 2004-06 University of Pittsburgh, MSc, Clinical Research Honors: 2010 Invited Faculty, American Society of Hematology Clinical Research Training Institute 2009 National Institutes of Health Pediatric Research Loan Repayment Program - Renewal 2007 National Institutes of Health Pediatric Research Loan Repayment Program 2007 Hemophilia and Thrombosis Research Society Career Development Award 2006 American Society of Hematology Fellow Scholar Award 2006 Wallace H. Coulter Foundation Scholar (awarded to the recipient of an ASH Scholar Award with the highest scored clinical/translational research application) 2005 American Society of Hematology Clinical Research Training Institute 2004 Hemophilia and Thrombosis Research Society, Clinical Thrombosis Research Award 2003 Mark A. Sperling Resident Research Award, Children’s Hospital of Pittsburgh 2003 Children’s Hospital of Pittsburgh Primary Care Award 2002 Region III Ambulatory Pediatric Association Research Award 2000 Alpha Omega Alpha Professional Memberships: 2003 American Society of Hematology 2004 American Society of Pediatric Hematology/Oncology 2004 Hemophilia and Thrombosis Research Society
  2. 2. 5/6/2010 Professional Activities: 2010 Review Panel, Pilot and Collaborative Translational and Clinical Studies Program, The Ohio State University CTSA 2009 Peer reviewer: Journal of Pediatrics (3), Pediatric Blood & Cancer (2), Clinical Therapeutics 20008-present Review Panel, Clinical and Translational Research Intramural Funding Program, The Research Institute at Nationwide Children’s Hospital 2008 Peer reviewer: Pediatric Blood & Cancer (5), Thrombosis Research, Journal of Pediatric Hematology/Oncology 2007 Peer reviewer: Journal of Pediatric Hematology/Oncology (2), Pediatrics, Journal of Pediatrics 2006 Peer reviewer: Journal of Pediatrics 2006 Abstract Reviewer/Oral Session Moderator, American Society of Hematology 2005 Peer reviewer, Pediatrics Peer-Reviewed Manuscripts: 2010 O'Brien, SH. Candrilli, SD. In the absence of a central venous line, risk of venous thromboembolism low in critically injured children, adolescents, and young adults: evidence from the National Trauma Data Bank. Pediatric Critical Care Medicine. (in press) 2010 O'Brien SH, Fan L, Kelleher KJ. Inpatient use of laxatives during opioid administration in children with sickle cell disease. Pediatric Blood & Cancer. 2010 Apr;54(4):559-62. Jan. PMID: 20049931 2009 O’Brien SH, Hankins JS. Decision analysis of treatment strategies in children with severe sickle cell disease. Journal of Pediatric Hematology & Oncology. 2009 Nov;31(11):873-8. PMID: 19829150 2009 O’Brien SH, Smith KJ. Using thrombophilia testing to determine anticoagulation duration in pediatric thrombosis is not cost-effective. Journal of Pediatrics. 2009 Jul;155(1):100-4. PMID: 19324372 2009 O'Brien SH. Secondary data demonstrate safety of splenectomy in spherocytosis. Pediatric Blood & Cancer. 2009 Jul;52(7):753-4. PMID: 19326407 2009 Cavo M, Wang W, O'Brien SH. Use of low molecular weight heparin for thromboprophylaxis in a pediatric inpatient population: reasons for use and incidence of bleeding complications. Thrombosis Research. 2009 Apr 13. [Epub ahead of print] PMID: 19368960 2009 Candrilli SD, Balkrishnan R, O’Brien SH. Effect of injury severity on the incidence and resource utilization-related outcomes of deep vein thrombosis among pediatric trauma admissions in the United States. Pediatric Critical Care Medicine. 2009 Sep;10(5):554-7. PMID: 19451844 2009 Hyatt SA, Wang W, Kerlin BA, O’Brien SH. Applying diagnostic criteria for type 1 von Willebrand disease to a pediatric population. Pediatric Blood & Cancer. 2009 Jan; 52(1): 102-7. PMID: 18816699
  3. 3. 5/6/2010 2008 Standridge SM, O’Brien SH. Idiopathic intracranial hypertension in a pediatric population: a retrospective analysis of the initial imaging evaluation. Journal of Child Neurology. 2008 Nov; 23(11): 1308-11. PMID: 18984841 2008 O’Brien SH, Haley K, Wang W, McKenna C, Perdue K, Gaines B. Variation in DVT prophylaxis for adolescent trauma patients: a survey of the Society of Trauma Nurses. Journal of Trauma Nursing. 2008;15(2):53-57. PMID: 18690134 2008 O’Brien SH. Decision analysis in pediatric hematology. Pediatric Clinics of North America. 2008 Apr;55(2):287-304. PMID: 18690134 2008 O’Brien SH, Kaizar EE, Gold MA, Kelleher KJ. Trends in prescribing patterns of hormonal contraceptives for adolescents. Contraception.2008 Apr;77(4):264-269. Epub 2008 Mar 4. PMID: 18342649 2007 O'Brien SH, Lee H, Ritchey AK. Once-daily enoxaparin in pediatric thromboembolism: a dose finding and pharmacodynamics/pharmacokinetics study. Journal of Thrombosis and Haemostasis. 2007 Aug 17;5(9):1985-1987. PMID: 17596139 2007 Lampel HP, Patel N, Boyse K, O’Brien SH, Zirwas MJ. Prevalence of hand dermatitis in inpatient nurses at a United States hospital. Dermatitis. 2007 Sep;18(3):140-2. PMID: 17725920 2007 Lee PL, Lemos B, O’Brien SH, English JC, Zirwas MJ. Cutaneous diphtheroid infection and review of other cutaneous Gram-positive Bacillus infections. Cutis. 2007 May;79(5):371-7. PMID: 17569399 2007 O’Brien SH, Ritchey AK, Ragni MV. Combined clotting factor deficiencies: experience at a single hemophilia treatment center. Haemophilia. 2007 Jan;13(1):26-9. PMID: 17212721 2007 O’Brien SH, Ritchey AK, Smith KJ. A cost-utility analysis of treatment for acute childhood idiopathic thrombocytopenic purpura (ITP). Pediatric Blood Cancer. 2007 Feb;48(2):173-80. PMID: 16550529 2004 O’Brien SH, Reis EC. Identification, evaluation, and management of obesity in an academic primary care center. Pediatrics. 2004 Aug;114(2). e154-9. PMID: 15286251 Scientific Abstracts: 2010 Reed S, Klima J, Schwarz EB, O’Brien SH. Prescription Contraception Use in Adolescents and Young Adults with Sickle Cell Disease: Analysis of Michigan Medicaid Claims. Poster presentation at 23rd annual meeting of the American Society of Pediatric Hematology/Oncology, April 7-10, 2010, Montréal, Quebec. Canada  2010 Setty B, O’Brien SH, Kerlin BA. Pediatric venous thromboembolism: redefining epidemiology. Abstract presentation at the National Conference on Blood Disorders in Public Health, Atlanta, GA, March 9-11, 2010. 2009 Marcus PD, Nire KG, Grooms L, Klima J, O’Brien SH. The power of a standardized bleeding score in diagnosing pediatric type 1 von Willebrand disease. Abstract presented at the 51st American Society of Hematology Annual Meeting, New Orleans, LA, December 5-8, 2009. 2009 Bollinger LM, Rhodes MM, Nire KG, Chisolm DJ, O’Brien SH. Caregivers’ perspectives on barriers to transcranial Doppler screening in children with sickle cell disease. Abstract presented
  4. 4. 5/6/2010 at the 51st American Society of Hematology Annual Meeting, New Orleans, LA, December 5-8, 2009. 2009 Candrill SD, O’Brien SH, Ware RE, Balkrishnan R. Hydroxyurea adherence and associated outcomes in Medicaid enrollees with sickle cell disease. Abstract presented at the 51st American Society of Hematology Annual Meeting, New Orleans, LA, December 5-8, 2009. 2009 Young G, Yee DL, Khanna R, O’Brien S, Nugent DJ. Fondaparinux for the treatment of thrombosis in children: a prospective, dose-finding, pharmacodynamic and safety study. Abstract presented at the 51st American Society of Hematology Annual Meeting, New Orleans, LA, December 5-8, 2009. 2009 Candrilli SD, Balkrishnan R, O'Brien SH. Changes in rates of sickle cell disease-related inpatient stays and associated resource use among African Americans in the United States following approval of hydroxyurea. Abstract presented at the ISPOR 12th Annual European Congress, October26, 2009 at Le Palais des Congrès de Paris in Paris, France. 2008 Powell KK, Wang W, Kelleher KJ, O’Brien SH. Use of SSRIs not associated with increased bleeding events in children: an analysis of the Michigan Medicaid database from 2000-2003. Abstract presented at the 50th annual American Society of Hematology Annual Meeting, San Francisco, CA, December 6-9, 2008. 2008 Gaines BA, O’Brien S, Rodeberg D, McKenna C, Miller M, Sippey M, Dickson J, Ritchey AK. Management of children at risk for deep venous thrombosis: results of a clinical guideline. Abstract presented at the 67th Annual Meeting of the American Association for the Surgery of Trauma, Maui, HI, September 24, 2008. 2008 Fernandez KS, O’Brien SH. Physician knowledge and attitudes regarding contraception and DVT risk in adolescents. Abstract presented at the 4th Annual Hemophilia and Thrombosis Research Society Scientific Symposium,Chicago, IL, April 17–19, 2008. Book Chapters: 2007 Ritchey AK, Keller FG, O’Brien SH. Hematologic Manifestations of Childhood Illness. In: Hoffman R, Benz EJ, Shattil SJ, Furie B, Cohen HJ, Silverstein LE, McGlave P (eds): Hematology. Basic Principles and Practice: 5th Ed. New York, Elsevier, Churchill Livingstone. (In Press) 2003 O’Brien S, Holtzer K. Hematology/Oncology. In: Kahan S, DeAntonis K. Pediatrics in a Page. Blackwell Publishing. 2003. Regional/National Speaking Engagements: 2010 Management and Prevention of Cancer-Related Thrombosis American Society of Pediatric Hematology/Oncology, 4/10/2010, Montreal, Canada 2007 Anticoagulation in Pediatrics: Thin Evidence on Blood Thinners in Kids National Hemophilia Foundation Annual Meeting, 11/1/2007, Denver, CO.
  5. 5. 5/6/2010 Funded Research Grant Number Title Role in Project Percentage Effort Years Inclusive Source 1R01HL095110-01 Dose-finding, Pharmacokinetic, Safety and Efficacy of Bivalirudin in Children Co-Investigator 2% PI = Guy Young 2008-2010 National Heart, Lung, Blood Institute R03 HS017344-01 DVT Prevention in Pediatric and Adolescent Trauma Patients: Safety and Costs Principal Investigator 15% 2007–2009 Agency for Healthcare Research and Quality R01 FD003091-03 Fondaparinum in children with thrombosis Co-Investigator (Site PI) 2% PI = Guy Young 2008–2009 Food and Drug Administration ASH Fellow Scholar Award Thrombophilia Screening in Children with Venous Thromboembolism: Cost- Effectiveness Analysis Principal Investigator 35% 2006–2008 American Society of Hematology Once-Daily Enoxaparin for the Treatment of Pediatric Thromboembolic Disease Principal Investigator 2005-2006 General Clinical Research Center, Children’s Hospital of Pittsburgh Hemophilia and Thrombosis Research Society

×